Docket #: S06-455
Monoclonal Antibody against human LMO2 Antigen
This antibody is directed against the human LMO2 antigen, which is expressed as a transcription factor in certain lymphomas and leukemias. We have recently shown that it identifies those lymphomas derived from germinal center B cells. These lymphomas are the subset with a better response to therapy and a better prognosis.
LMO2 gene translocations have been found in a subset of human T cell acute leukemias.
The LMO2 gene was a site of specific integration of gene therapy vectors which caused leukemia.
Applications
- Useful in classification of human lymphoma and leukemia.
- Useful in establishing prognosis in human lymphoma and leukemia
Similar Technologies
-
MECA-32 S96-104MECA-32
-
Chromatin in-vivo Assay (CiA) mouse S11-188Chromatin in-vivo Assay (CiA) mouse
-
Chimeric pseudoislets development method that retains beta cell features S22-359Chimeric pseudoislets development method that retains beta cell features